- Company Details
DESCRIPTION provided by applicant A Phase II SBIR program of preclinical development is proposed for the development of an active specific immunotherapeutic called Cellariumandquot for treatment o ...SBIRPhase II2016Department of Health and Human Services National Institutes of Health
DESCRIPTION (provided by applicant): A Phase I SBIR program of preclinical development is proposed focusing on the development of an active specific immunotherapeutic called Cellarium for treatm ...SBIRPhase I2010Department of Health and Human Services
IN CYTU, INC.
LINCOLN, RI, 02865-4257
|# of Employees:||0|
|Socially and Economically Disadvantaged:||N|